ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer
Main Authors: | Jie Wang, Yuhan Xiao, Dengxiong Li, Chi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Asian Journal of Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958423011053 |
Similar Items
-
KRT72 might serves as a prognostic biomarker for patients with prostate cancer
by: Jie Wang, et al.
Published: (2023-11-01) -
Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer
by: Dechao Feng, et al.
Published: (2022-10-01) -
Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients
by: Dechao Feng, et al.
Published: (2023-07-01) -
HSD17B1 could serve as a prognostic biomarker for urinary bladder patients
by: Jie Wang, et al.
Published: (2023-11-01) -
TEX19 could function as a prognostic biomarker for prostate cancer
by: Yuhan Xiao, et al.
Published: (2023-12-01)